Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China
Open Access
- 3 July 2007
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 7 (1), 120
- https://doi.org/10.1186/1471-2407-7-120
Abstract
Background: Although methylation-mediated inactivation of expression of RASSF1A, a candidate tumor suppressor gene, has been observed in several human cancers, the data concerning alteration of RASSF1A expression and methylation in Chinese primary gastric cancer are scarce. Moreover, direct evidence showing the association between protein expression of RASSF1A and primary human cancers is lacking. The aim of this study was to investigate RASSF1A expression in tissue of primary gastric cancer (GC) at mRNA and protein levels, and to establish the possible relationship between DNA methylation status and protein expression of RASSF1A in Chinese.Methods: Fifty-four patients with primary gastric cancers were included in the study of RASSF1A mRNA expression and methylation status between the cancer tissue and the corresponding adjacent normal tissue. 20 out of 54 patients were included for study of RASSF1A protein expression. The expression of RASSF1A at mRNA and protein levels was determined by RT-PCR and Western-blotting, respectively. The RASSF1A promoter methylation was detected by methylation-specific PCR.Results: RASSF1A mRNA and protein expressions in GC were reduced significantly with comparison to the corresponding normal tissues (OD value: 0.2589 ± 0.2407 vs 0.5448 ± 0.2971,P< 0.0001; 0.1874 ± 0.0737 vs 0.6654 ± 0.2201,P< 0.0001, respectively). Methylation frequency of RASSF1A in primary GC is higher than that in the corresponding normal tissues (66.7% vs. 14.8%,P< 0.0001). Furthermore, RASSF1A mRNA expression in methylation group of GC was further reduced when compared to the unmethylation group of GC (0.1384 ± 0.1142 vs. 0.5018 ± 0.2463,P< 0.0001).Conclusion: Expression of RASSF1A was reduced in tissue of GC at mRNA and protein levels. Diminished expression of RASSF1A was associated with the promoter methylation.Keywords
This publication has 26 references indexed in Scilit:
- Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrestOncogene, 2004
- A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic StabilityCancer Research, 2004
- RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule DynamicsCancer Research, 2004
- Haploinsufficiency for tumour suppressor genes: when you don't need to go all the wayBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complexNature, 2004
- Promoter hypermethylation of tumor‐related genes in gastric intestinal metaplasia of patients with and without gastric cancerInternational Journal of Cancer, 2002
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- Epstein-Barr Virus-Positive Gastric Carcinoma Demonstrates Frequent Aberrant Methylation of Multiple Genes and Constitutes CpG Island Methylator Phenotype-Positive Gastric CarcinomaThe American Journal of Pathology, 2002
- Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 2001
- Accommodating haploinsufficient tumour suppressor genes in Knudson's modelOncogene, 2000